Foresite Capital Management V, LLC Q4 2025 Filing
Filed February 17, 2026
Portfolio Value
$164.4M
Holdings
7
Report Date
Q4 2025
Filing Type
13F-HR
All Holdings (7 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ALMSALUMIS INC. | 5,779,348 | $56.4M | 34.31% | |
| 2 | CGONCG Oncology, Inc. | 1,004,050 | $41.7M | 25.36% | |
| 3 | IRONDisc Medicine, Inc. | 299,069 | $23.7M | 14.45% | |
| 4 | NTRANatera, Inc. | 67,356 | $15.4M | 9.39% | |
| 5 | LYELLyell Immunopharma, Inc. | 477,078 | $14.7M | 8.93% | |
| 6 | HIMSHims & Hers Health, Inc. | 273,151 | $8.9M | 5.39% | |
| 7 | MAZEMaze Therapeutics, Inc. | 86,291 | $3.6M | 2.17% |